الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
32 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
34 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Dr. Hanaan Ahmed Mohammed Ahmed 2021
35 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Dr. Ahmed Mubarak Hefni Ismail 2021
36 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Dr. Maged Abdelfatah Amine Hassan 2021
37 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Maged Abdelfatah Amine Hassan 2021
38 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
39 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
40 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Mayada Fawzy Sedik Farghaly 2021